Psychedelic frees up depressed brain, study shows

About Albert Labs

We are a pharmaceutical company leveraging our drug development and clinical research expertise to accelerate the development of highly effective mental health medicines.

If you would like support or more information around making an investment, please contact [email protected]

Complete this form to receive corporate updates and further details on how to invest in Albert Labs. By completing this form, you agree to our privacy policy.

Name*
First Last
Email*
Phone
Name
This field is for validation purposes and should be left unchanged.

41074

By completing this form you agree to our privacy policy. You will be sent corporate updates and further details including how to invest in Albert Labs.

You Might Also Like

Magic Mushrooms and Ecstasy: New Treatment For Autism Spectrum Disorders?

Two thirds of physicians surveyed believe psilocybin therapy has potential benefit for patients with treatment-resistant depression

6 terminally ill cancer patients in Canada received doses of the psychoactive substance found in ‘magic’ mushrooms after authorities eased rules

About Albert Labs